Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Transgene S.A. | -1.530% | -1.606% | -8.752% | -41.736% | -26.866% | -55.046% | -43.483% |
Minerva Neurosciences Inc. | -1.540% | -3.053% | -18.065% | -69.175% | -56.470% | -77.782% | - |
Aptose Biosciences | -1.550% | - | - | - | - | - | - |
Kyowa Hakko Kirin Co. Ltd. | -1.610% | 2.762% | 5.085% | 7.514% | 25.676% | -29.545% | 23.802% |
Corbus Pharmaceuticals Holding Inc. | -1.610% | 1.220% | -8.624% | 38624.728% | 38624.728% | 57.271% | -69.614% |
China Shineway Pharmaceutical Group Ltd. | -1.640% | 5.172% | -5.181% | 5.172% | 12.963% | 5.780% | 43.192% |
Seres Therapeutics Inc | -1.650% | -3.666% | -25.094% | -76.320% | -37.817% | -85.562% | - |
Syndax Pharmaceuticals Inc | -1.660% | -3.261% | -15.238% | 4.094% | -4.813% | 48.333% | - |
Mesoblast Ltd. | -1.720% | 8.411% | -17.143% | 176.190% | 218.681% | -53.339% | -31.288% |
Dermira Inc | -1.740% | - | - | - | - | - | - |
CASI Pharmaceuticals Inc. | -1.850% | - | - | - | - | - | - |
Aveo Pharmaceuticals Inc. | -1.910% | - | - | - | - | - | - |
Collegium Pharmaceutical Inc | -1.920% | -0.637% | 7.586% | 45.794% | 13.869% | 109.396% | 211.813% |
Agenus Inc. | -1.970% | - | - | - | - | - | - |
Peptidream Inc. | -2.110% | - | - | - | - | - | - |
Nicox S.A. | -2.130% | 6.525% | -5.890% | -62.590% | -63.231% | -95.364% | -96.555% |
Synthetic Biologics Inc. | -2.220% | -7.373% | -18.165% | -64.673% | -55.400% | -95.518% | -94.904% |
Inovio Pharma | -2.240% | - | - | - | - | - | - |
X4 Pharmaceuticals, Inc. | -2.250% | -8.902% | 1.860% | -50.227% | -29.808% | - | - |
Eagle Pharmaceuticals Inc | -2.270% | -8.808% | -34.815% | -77.290% | -26.667% | -91.415% | -92.951% |
Biofrontera AG | -2.370% | - | - | - | - | - | - |
Essex Bio-Technology Ltd | -2.420% | - | - | - | - | - | - |
Adverum Biotechnologies Inc. | -2.650% | - | - | - | - | - | - |
Pluristem Therapeutics Inc. | -2.750% | - | - | - | - | - | - |
Viking Therapeutics Inc | -2.850% | 1.802% | -4.589% | 282.487% | 197.283% | 936.697% | 781.166% |